Active Ingredient History
The vitamin E family comprise four tocotrienols and four tocopherols. The critical chemical structural difference between tocotrienols and tocopherols is that tocotrienols have unsaturated isoprenoid side chains with three carbon-carbon double bonds versus saturated side chains for tocopherols. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Amyotrophic Lateral Sclerosis (Phase 2)
Atrial Fibrillation (Phase 2/Phase 3)
Attention Deficit Disorder with Hyperactivity (Phase 2/Phase 3)
Breast Neoplasms (Phase 2)
CADASIL (Phase 2)
Cognitive Dysfunction (Phase 3)
Colorectal Neoplasms (Phase 2)
Diabetic Neuropathies (Phase 3)
End Stage Liver Disease (Early Phase 1)
General Surgery (Early Phase 1)
Healthy Volunteers (Phase 1)
Heart Failure (Early Phase 1)
Hypercholesterolemia (Phase 3)
Ischemic Stroke (Phase 3)
Lung Diseases (Early Phase 1)
Lung Neoplasms (Phase 3)
Muscle Strength (Phase 1/Phase 2)
Neurodegenerative Diseases (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Obesity (Phase 1/Phase 2)
Obesity, Morbid (Early Phase 1)
Osteoporosis (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 2)
Parkinson Disease (Phase 2)
Postmenopause (Phase 1/Phase 2)
Steatitis (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue